Page last updated: 2024-11-05

ethyl palmitate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl palmitate is an ester formed from the reaction of palmitic acid (a saturated fatty acid) and ethanol. It is a colorless, odorless liquid that is insoluble in water but soluble in most organic solvents. It is commonly found in palm oil and is used in a variety of applications, including cosmetics, pharmaceuticals, and food additives. In cosmetics, it is used as a skin-conditioning agent, emollient, and lubricant. In pharmaceuticals, it is used as an excipient and a carrier for other drugs. In food, it is used as a flavoring agent and a fat replacer. It is also used as a biofuel and a plasticizer. Ethyl palmitate is a relatively safe compound and has low toxicity. It is considered a good alternative to animal-derived fats and oils.'

ethyl hexadecanoate : A long-chain fatty acid ethyl ester resulting from the formal condensation of the carboxy group of palmitic acid with the hydroxy group of ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12366
CHEMBL ID3561042
CHEBI ID84932
SCHEMBL ID120620
MeSH IDM0051023

Synonyms (67)

Synonym
628-97-7
ethyl palmitate
nsc-8918
palmitic acid, ethyl ester
nsc8918
hexadecanoic acid, ethyl ester
ethyl hexadecanoate
inchi=1/c18h36o2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20-4-2/h3-17h2,1-2h
hexadecanoic acid,ethyl ester mfc18 h36 o2
ethyl palmitate, >=99%
ethyl palmitate, >=95%, fg
palmitic acid ethyl ester
QSPL 072
P0003
A801217
AKOS004910397
hexadecanoic acid ethyl ester
QSPL 205
QSPL 171
hexadecanoic acid,ethyl ester
LMFA07010471
we(2:0/16:0)
dtxsid2047511 ,
cas-628-97-7
tox21_302505
NCGC00256913-01
dtxcid0027511
CHEBI:84932
S9372
ethyl palmitate (natural)
nsc 8918
fema no. 2451
ird3m534zm ,
unii-ird3m534zm
einecs 211-064-6
ai3-06331
ethyl cetylate
FT-0625787
ethyl palmitate [inci]
ethyl palmitate [fhfi]
ethyl palmitate [usp-rs]
SCHEMBL120620
AC-35085
ethyl n-hexadecanoate
HMS3650O17
CHEMBL3561042
mfcd00008996
ethyl palmitate, analytical standard
3-trifluoromethyl-o-toluanilide
ethyl palmitate, united states pharmacopeia (usp) reference standard
ethyl palmitate, vetec(tm) reagent grade, 95%
ethyl palmitate, natural (us), >=95%, fg
hexadecanoic acid-ethyl ester
ethyl palmitate; hexadecanoic acid ethyl ester
hexadecanoic acid,ethyl ester mfc18 h36 o2
ethyl hexadecanoate (ethyl palmitate)
palmitic acid, ethyl ester (8ci)
fema 2451
SR-01000946821-1
sr-01000946821
Q18354123
CCG-267313
CS-0018590
HY-N2086
AS-57139
A868321
ethyl palmitate, 1mg/ml in acetonitrile

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" EP in dosage of 3 mg per mouse administered 48 hrs."( Role of macrophages in experimental malaria: V--Effect of ethyl palmitate on macrophages in Plasmodium berghei infected mice.
Devi, CU; Pillai, CR, 1997
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
hexadecanoate esterA fatty acid ester obtained by condensation of the carboxy group of palmitic acid with a hydroxy group of an alcohol or phenol.
long-chain fatty acid ethyl esterA fatty acid ethyl ester resulting from the formal condensation of the carboxy group of a long-chain fatty acid with the hydroxy group of ethanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency15.35530.000221.22318,912.5098AID1259243
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency0.00970.003041.611522,387.1992AID1159552
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (13.64)18.7374
1990's10 (22.73)18.2507
2000's10 (22.73)29.6817
2010's13 (29.55)24.3611
2020's5 (11.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.66 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index60.33 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]